Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-28

Clinical Trial Update: Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether progesterone administration can influence drug-induced QT interval lengthening; results have been posted for this study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Indiana University | Conditions: Prolonged QT Interval in EKG and Sudden Death | Phase 2 | Status: COMPLETED | Results posted: 2015-09-28